BRIEF published on 06/29/2026 at 11:05, 1 month 27 days ago MustGrow Biologics Corp: Strategic Shift and Financial Outlook Revenue Growth Strategic Transition MustGrow Biologics TerraSante Biologicals Market
PRESS RELEASE published on 06/29/2026 at 11:00, 1 month 27 days ago Original-Research: MustGrow Biologics Corp. (von GBC AG): BUY MustGrow Biologics Corp., a Canadian agricultural biologicals company, transitions to a more focused platform with commercial success of TerraSante product and strategic Bayer partnership Commercialization TerraSante MustGrow Biologics Corp Agricultural Biologicals Bayer Partnership
BRIEF published on 02/19/2026 at 10:05, 6 months 7 days ago MustGrow Biologics Corp. Advances Sustainable Agriculture Sustainable Agriculture Market Expansion Regenerative Solutions MustGrow Partnership Biological Technology
PRESS RELEASE published on 02/19/2026 at 10:00, 6 months 7 days ago Original-Research: MustGrow Biologics Corp. (von GBC AG): Management interview MustGrow Biologics Corp. is at the forefront of commercializing regenerative agriculture with innovative biological technologies, providing eco-friendly alternatives to synthetic chemicals and fertilizers Innovation Regenerative Agriculture Eco-friendly Biological Technologies MustGrow Biologics Corp.
Published on 08/27/2026 at 00:05, 59 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 2 hours 4 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 2 hours 34 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 2 hours 34 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 3 hours 49 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 1 hour 59 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 6 hours 20 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 6 hours 24 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 6 hours 34 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 7 hours 4 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 7 hours 2 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 7 hours 4 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 7 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 7 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026